Abstract-The interactions between natural and synthetic materials and blood components are analyzed with emphasis on the interdependence between biomaterials research and development and ultimate applications. Two new synthetic polymers, perfluorobutyryl ethylcellulose and polyalkylsulfone, that combine desirable blood compatibility and gas-to-blood transfer rates are discussed in terms of their potential usefulness for membrane oxygenators. Among the several hydrogels, polyacrylamide covalently grafted onto segmented polyether-urethane substrates showed essentially no platelet adhesion and adsorbed the least plasma proteins in comparison to other systems. Polymerie composites having stiffness, anisotropies that approximate living tissues, and the ability to culture cells and hence to maintain a living cellular interface between ftowing blood and microfiber substrates, are expected to expand the horizons for biomaterials in prosthetic applications.
INTRODUCTION
Biomaterials are materials that can be implanted in the body to provide special prosthetic functions or used in diagnostic, surgical and therapeutic applications without causing adverse effects on blood or other tissues. ' Blood compatible materials constitute a significant part of bimaterials and are restricted to applications in which the contacting fluid is blood. Examples are blood oxygenating membranes in artificial lungs, blood storage bags, blood pumps in circulatory assistance devices, membranes for artificial kidney machines, catheters, shunts, cannulae, sutures, and controlled drug release capsules. Blood compatibility is a broad term and has often been misused to denote performance of biomaterials based on a single or a few in vitro tests that frequently ignore the existence of hemorheological parameters. A truly blood compatible material must not adversely interact with blood components to cause clotting of plasma and Iead to thrombosis, or cause other adverse toxic and immunological responses, and cancer. Furthermore, the materials must also be able to perform physical functions and hence must be designed to meet these objectives. [2] [3] [4] [5] Although numerous dogmatic attempts have been made to single out one or more parameters such as wettability, critical surface tension, and surface charge, the decisive events that control blood compatibility occur at the molecular Ievel and are significantly controlled by hemorheological factors of the physiological environment. The Iack of understanding of these events still hampers progress although semi-empirical approaches, which are often desirable, resulted in the development of a number of materials that contributed significantly to biomedical science and clinical practice.
DISCUSSION

Interactions of blood components with surfaces
It is now established that among the initial events that occur when materials contact blood is the very rapid adsorption of plasma protiens. [6] [7] [8] This process seems tobe completed in less than 3 sec and effectively inftuences the subsequent interactions of the formed blood elements, especially the platelets with the proteinated surfaces. This is not to say that platelets cannot interact with "bare" surfaces in the absence of blood, but in the presence of blood they apparently contact an already deposited protein layer or layers. The adsorption of proteins from plasma is inftuenced by the type of surface, hemorheological parameters, and quite possibly by the !arge number of small ionic species present in plasma which are expected to arrive at a given surface prior to proteins. In other words, the adsorption of proteins may be mitigated by a number of parameters, including other plasma components. The term "conditioning" or "passivating" layer has been coined, 9 but is frequently incorrectly interpreted since not all proteinated surfaces remain "passive" toward blood components but, in fact, can result in platelet adhesion, activation and aggregation leading to thrombosis. In reality, the adsorbed proteins do not become permanently immobilized on the surface of a material in the physiological environment. They can be enzymatically degraded, replaced by other proteins, or can undergo various conformational and configurational changes, and denaturation.'·'" All these play a dominant roJe in the activation of plasma coagulation factors, mostly factors XII and XI, and affect the formed blood elements, especially the platelets. When platelets adhere to proteinated surfaces they may become activated depending on the molecular stimuli and hemorheological factors, extrude their granules, liberate adenosine nucleotides, serotonin, and other coagulation activators. 11 As a consequence, irreversible platelet aggregation results, leading to thrombosis. As indicated schematically in Fig.  1 , the process involves at least three major steps: (a) adsorption of and subsequent changes in plasma proteins, (b) clotting of the plasma proteinsvia a complex series of reactions involving the various clotting factors, and (c) activation of the platelets and their aggregation in conjunction with the other formed blood elements. A thrombus or blood clot represents an interwoven mesh of fibrin (polymerized and crosslinked fibrinogen), platelets, and red and white cells. 12 
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The situation is even more complex in the case of natural surfaces. When the endothelial lining of a blood vessel is injured, collagen may become exposed which then promotes the adhesion, activation, and aggregation of the platelets." This property of collagen appears to be related to its particular molecular architecture and resultant physiochemical properties. 13 U nder normal conditions, the ftowing blood is apparently not in direct contact with endothelial cells which line the blood vessel walls, but with an adsorbed layer of proteins. 14 The formation of a multilayer of plasma proteins following the initial adsorption of a monolayer could be influenced by changes in the solubility of the proteins, especially fibrinogen, the solubility of which is quite low in plasma.
The adsorption process will also be influenced by hemorheological factors. These are often ignored, yet the successful performance of a given material in even the simplest device will be influenced by rheological considerations. Research on the better understanding of the molecular interactions between flowing blood components and materials must proceed in parallel with the development and the physico-chemical and biological testing of biomaterials. Since the surface properlies of biomaterials are of great significance, the various steps that Iead toward the design of medical devices should insure that these properlies are maintained and checked throughout the numerous operations. Figure 2 illustrates the relationship between biomaterials R & D and applications. It is evident that this represents an interdisciplinary area requiring close collaboration between physical, biological, and medical disciplines.
Biomaterials in blood contacting applications
Despite the relative ignorance about the molecular and hemorheological events that are involved in blood compatibility, a number of synthetic polymers have been prepared which exhibit little adverse effects on blood components and at the same time retain their physical properlies for various periods of time in the physiological environment. These combined biological and physical properlies make them useful for various prosthetic and other biomedical applications in surgery and therapy. Research and development on blood compatible materials may be depicted schematically, as shown in Fig. 3 , to include studies of : (1) natural macromolecules, (2) synthetic macromolecules (including surface modifications), (3) microfibers (including tissue culture approaches), (4) technology, (5) biological properties, (6) biological testing according to a carefully designed protocol, and (7) physico-chemical properties. Significant practical accomplishments include (a) the development of isotropic (L Tl) carbons having the required compatibility with blood and mechanical strength to be useful in thousands of cardiac heart valve replacements; 15 (b) the heparinization of various polymers by surface treatments, '6-20 thus making these useful especially in short-term applications such as shunts, catheters, and cannulae; (c) the development of a family of segmented polyether-urethanes especially useful for subsequent surface modifications to enhance their blood compatibility and for various medical devices requiring physical performance; 21 -23 (d) the development of thin perfluorobutyryl ethylcellulose 24 and polyalkylsulfone membranes especially useful for blood oxygenators; 25 (e) the application of glow discharge techniques that enables the surface modification of polymers to impart blood compatibility to them with pure monomers such as silica-free hexamethyldisiloxane and the system of acetylene-NrH20; 26 ' 27 and (f) the development of blood compatible hydrogels (three-dimensional networks of macromolecules that can imbibe !arge quantities of water) which can subsequently be grafted onto other polymers to give them proper physical strength. 1 • 2 g._ 32
Extracorporeal assist devices, such as blood oxygenators, require polymeric membranes having both good blood compatibility and high gas transmission rates toward oxygen and carbon dioxide. Two promising synthetic polymers mentioned above are under investiga- ). The combination of the promising biological properties and high gas-to-blood transfer rates toward oxygen and carbon dioxide, make these membranes potentially useful candidates for blood oxygenators. This could eliminate the need to use heparinised surface coatings in oxygenator applications to prevent thrombosis. Although it has been shown recently that silica-free polydimethylsiloxane exhibits considerably improved blood compatibility in comparison to the commercial silica reinforced silicone, the above described two synthetic membranes are inexpensive and can be readily prepared and Iaminated onto porous surfaces without pinholes. Among other types of materials, covalently grafted hydrogels are useful in a variety of applications, including coatings of catheters, shunts, cannulae, oxygenator membranes, artifi.cial kidney membranes, encapsulants of carbon particles used in hemodialysis in acute hepatic failure and others. As summarized in Table 1 , there are essentially three techniques for the covalent grafting of hydrogels to appropriate substrates: (1) chemical (cericion) initiation, (2) microwave discharge, and (3) high energy irradiation ( 60 Co; Van de Graaf). Preliminary comparative evaluation of one ionic and two non-ionic hydrogels grafted onto polymeric substrates, namely poly(2-hydroxyethylmethacrylate), poly(vinylacetate-co2%crotonic acid) 60% sodium ionomer, and polyacrylamide indicates that ionic groups on the hydrogel are not essential for blood compatibility. The biological performance of the grafted hydrogels seems tobe related to the extent of protein adsorption, desorption, and/or conformational and confi.gurational changes, and to the subsequent interactions with blood elements, especially the platelets .. These events in turn depend, among others, on the chemiCal composition, purity, particular preparative conditions, crosslinking density, and the Ievel of water uptake. 1 ' 4 ' 33 It should be stressed that the Ievel of water uptake and/or the existence of an organized water structure are insuffi.cient parameters to explain blood compatibility since numerous highly hydrophilic surfaces do not show acceptable biological performance. However, at least in the case of the non-ionic polyacrylamidegrafted hydrogels, it seems that for optimum blood compatibility an equilibrium water uptake of 60-80% is required prior to implantation, coupled with a low crosslinking density and a graft thickness of about 3-5 ~m. 1 ' 4 ' 33 ' 34 The available evidence strongly suggests that for optimum blood compatibility, an equilibrium water uptake approaching the above range is needed also with the two other hydrogel systems. Recent results shown in Tables 2 and 3 , respectively, indicate that grafted polyacrylarnide elicits no platelet adhesion and adsorbs the least plasma proteins, especially fibrinogen, gammaglobulin, and albumin. 35 It is interesting that in the case of poly(2-hydroxyethylmethacrylate) the equilibrium water Table 2 . Platelet adhesion from heparinised whole canine blood to polyacrylamide hydrogel covalently grafted onto polyurethane in rotaring disc experiments at 400 rpm after 3 min ( data from
Ref . uptake is limited to approximately 30-35% owing to phase Separation and can be changed by copolymerization with hydrophilic monomers. These systems have shown applications in soft contact Jenses as weil as in other areas, and their tissue compatibility has been demonstrated. 36 ' 37 To estimate the biological performance of biomaterials, in vitro, ex vivo, and in vivo procedures are necessary with suitable animals. It is important to consider any species-related difference, hemodynamic parameters, statistically significant number of tests, and the overall performance of materials in devices. Although there are a number of test procedures under development, the two most widely used in vivo procedures for thrombosis formation have been the vena cava and the renal embolus tests. Table 4 summarizes the in vivo results of selected biomaterials based on these two tests. It should be pointed out that in each case at least six tests were performed on each material. In the case of the vena cava ring tests, the term "excellent" means that there was no or only minimal thrombus formation after 2-hr or 2-weeks, "good" means that at least two-thirds of the rings bad either no or only minimal thrombus formation after 2-hr or 2-weeks, and "fair" means that approximately one-half of the rings remained essentially thrombus free after 2-hr or 2-weeks. It should be stressed that both the vena cava and renal embolus test systems should be considered as important, qualitative prelirninary indicators of the blood compatibility of candidate materials and must be supplemented by a variety of other tests.
To provide blood compatible surfaces, investigations are also underway to create a viable cellular interface on specially prepared nonwoven rnicrofiber scaffold structures/8 and to use denatured tissue components in polymers, so-called "biolized" materials. 39 In the former approach, blood contacts a living cellular layer rather than the polymer itself, whereas in the latter, the blood contacting interfaces are denatured and crosslinked tissue components.
As it was mentioned above, the application of glow-discharge techniques with pure monomers of hexamethyldisiloxane showed promising blood compatibility based on in vitro andin vivo animal data. 27 This biological performance is probably related to the absence of silica 28 Also under development are novel anisotropic block polymer Iaminates with directional stiffness ratios similar to those of natural tissue components of the body, especially heart valves. 40 This as weil as other approaches that recognize the anisotropy of natural tissues should make it possible to design novel artificial Ieaflet heart values for eventual clinical use in conjunction with various surface treatments to achieve blood compatibility. 41 
CONCLUSIONS
It is imperative to understand better the events that take place at the molecular Ievel under the rheological conditions of the physiological environment when blood contacts artificial surfaces and the natural tissue components. This information then must be applied to the synthesis and modifications of polymers and related to specific clinically useful diagnostic, surgical and therapeutic uses. It should be recognized that materials must be developed for particular biomedical applications because no single material can fulfill the functions of all requirements.
